RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS)
$0.085 0.025 (41.6667%)
Analysed RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) News Sources
Rapid Dose Therapeutics Launches QuickStrip(TM) Medical Cannabis for Patients in Brazil following ANVISA Approval of Sublingual and Buccal Formats for Medical Treatment
10-02-2026
yahoo.com
Rapid Dose Therapeutics (DOSE) (RDTCF) Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets
13-04-2026
yahoo.com
Rapid Dose Therapeutics Extends Strategic Collaboration with Global Nicotine Leader and Initiating Saudi Arabia Commercialization
07-07-2026
yahoo.com
Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt
10-07-2026
yahoo.com
Rapid Dose Therapeutics (DOSE) (RDTCF) and Bodhi Health Expand Distribution and Sales of CurcuWIN(R) QuickStrip(TM) Curcumin Across Canada
28-07-2026
yahoo.com
Rapid Dose Therapeutics and Aavishkar Granted Monolayer QuickStrip(TM) Nicotine Patent, Advancing RDT's Global Commercialization Strategy
20-08-2026
yahoo.com
What is the current price of RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS)?
The current price of RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) is $0.085.
RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) since the previous trading day is $0.025.
RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) since the previous trading day is 41.6667%.
What is the most recent average sentiment score for RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS)?
The most recent average sentiment score for RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) is 73 out of 100.
What is the most recent average sentiment for RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS)?
The most recent sentiment for RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS) is .
SEC-8K** Filing Available For RAPID DOSE THERAPEUTICS CORP (RDTCF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.